# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $66 price target.
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $54 to $66.
Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Overweight and lowers the price target from $68 t...
Oppenheimer analyst Steven Lichtman maintains RxSight (NASDAQ:RXST) with a Outperform and lowers the price target from $72 t...
Stifel analyst Thomas Stephan maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $70 to $65.